Flinton Capital Management LLC grew its position in Humana Inc. (NYSE:HUM) by 868.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,096 shares of the insurance provider’s stock after acquiring an additional 12,640 shares during the period. Flinton Capital Management LLC’s holdings in Humana were worth $3,392,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Guardian Life Insurance Co. of America raised its stake in shares of Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after acquiring an additional 4 shares during the last quarter. Acrospire Investment Management LLC bought a new position in shares of Humana in the second quarter valued at approximately $120,000. Independent Portfolio Consultants Inc. raised its stake in shares of Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock valued at $125,000 after acquiring an additional 94 shares during the last quarter. Point72 Asia Hong Kong Ltd bought a new position in shares of Humana in the first quarter valued at approximately $128,000. Finally, Northwestern Mutual Wealth Management Co. raised its stake in shares of Humana by 139.5% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock valued at $134,000 after acquiring an additional 325 shares during the last quarter. Institutional investors own 95.12% of the company’s stock.

In related news, CEO Bruce D. Broussard sold 12,000 shares of the firm’s stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $251.88, for a total transaction of $3,022,560.00. Following the transaction, the chief executive officer now directly owns 80,086 shares of the company’s stock, valued at $20,172,061.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP M Todoroff Christopher sold 22,935 shares of the firm’s stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $252.52, for a total transaction of $5,791,546.20. Following the transaction, the vice president now directly owns 24,001 shares in the company, valued at $6,060,732.52. The disclosure for this sale can be found here. Insiders sold 55,595 shares of company stock worth $14,133,706 over the last ninety days. Insiders own 0.80% of the company’s stock.

Shares of Humana Inc. (NYSE:HUM) traded down 0.16% during midday trading on Thursday, reaching $246.11. 185,592 shares of the company’s stock traded hands. The stock has a market cap of $35.57 billion, a P/E ratio of 20.25 and a beta of 0.86. The stock has a 50 day moving average of $249.17 and a 200-day moving average of $234.01. Humana Inc. has a 12 month low of $163.50 and a 12 month high of $259.76.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, beating analysts’ consensus estimates of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The firm had revenue of $13.53 billion for the quarter, compared to analyst estimates of $13.61 billion. During the same period last year, the firm earned $2.30 earnings per share. On average, equities research analysts forecast that Humana Inc. will post $11.55 EPS for the current fiscal year.

The firm also recently disclosed a dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 29th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s dividend payout ratio (DPR) is 13.06%.

A number of research analysts have recently issued reports on the stock. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $273.00 target price for the company in a research note on Tuesday. Cowen and Company reissued an “outperform” rating and issued a $275.00 price target (up previously from $230.00) on shares of Humana in a report on Wednesday, September 20th. ValuEngine raised shares of Humana from a “hold” rating to a “buy” rating in a report on Friday, September 1st. BidaskClub raised shares of Humana from a “sell” rating to a “hold” rating in a report on Wednesday, August 23rd. Finally, Morgan Stanley raised their price target on shares of Humana from $269.00 to $276.00 and gave the company an “overweight” rating in a report on Thursday, August 17th. Nine research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $247.50.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another publication, it was illegally copied and reposted in violation of United States & international trademark and copyright laws. The legal version of this news story can be viewed at https://www.watchlistnews.com/humana-inc-hum-shares-bought-by-flinton-capital-management-llc/1610395.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.